Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

12/6/24 10:11:29 AM ET

Medical/Dental Instruments

Health Care

Get the next $XRAY alert in real time by email

SC 13G/A 1 UnitedStates_13G__DENTSPLYSI.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 17)* (Name of Issuer) DENTSPLY SIRONA Inc (Title of Class of Securities) Common Stock (CUSIP Number) 24906P109 (Date of Event Which Requires Filing of this Statement) November 29, 2024 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, an* d for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of * the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 24906P109 (1) Names of reporting persons The Vanguard Group (2) Check the appropriate box if a member of a group (a) (see instructions) (b) X (3) SEC use only (4) Citizenship or place of organization Pennsylvania Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power 149,574 (7) Sole dispositive power 19,884,312 (8) Shared dispositive power 395,273 (9) Aggregate amount beneficially owned by each reporting person 20,279,585 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 10.20% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: DENTSPLY SIRONA Inc Item 1(b) Address of issuer's principal executive offices: 13320 Ballantyne Corporate Pl Charlotte, NC 28277 Items 2(a)-2(c). Name, Address Of principal business office, and Citizenship of* persons filing: The Vanguard Group - 23-1945930 100 Vanguard Blvd. Malvern, PA 19355 2(d) Title of class of securities: Common Stock 2(e) CUSIP Number: 24906P109 Item 3. This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). Item 4. Ownership As of the close of business on November 29, 2024: (a) Aggregate amount beneficially owned: 20,279,585 (b) Percent of class: 10.20% (c) Number of shares as to which person has: 1. The Vanguard Group (a) Amount beneficially owned: 20,279,585 (b) Percent of class: 10.20% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 149,574 (iii) Sole power to dispose or to direct the disposition of: 19,884,312 (iv) Shared power to dispose or to direct the disposition of: 395,273 Item 5.Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . Item 6. Ownership of More than 5 Percent on Behalf of Another Person. The Vanguard Group, Inc.'s clients, including investment companies registered u* nder the Investment Company Act of 1940 and other managed accounts, have the ri* ght to receive or the power to direct the receipt of dividends from, or the pro* ceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5* %. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below I certify that, to the best of his/her knowledge and belief, t* he securities referred to above were not acquired and are not held for the pur* pose of or with the effect of changing or influencing the control of the issuer* of the securities and were not acquired and are not held in connection with or* as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 06, 2024 THE VANGUARD GROUP By: /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

Get the next $XRAY alert in real time by email

Recent Analyst Ratings for

$XRAY

Date	Price Target	Rating	Analyst
4/15/2025	$14.00	Overweight → Equal-Weight	Morgan Stanley
3/13/2025		Buy → Hold	Needham
2/14/2025	$20.00	Equal Weight	Wells Fargo
1/23/2025	$30.00 → $20.00	Buy → Hold	Jefferies
1/7/2025	$20.00	Outperform → In-line	Evercore ISI
12/4/2024	$21.00	Neutral	Mizuho
11/7/2024		Outperform → Market Perform	Leerink Partners
10/25/2024	$34.00 → $29.00	Buy	Needham

More analyst ratings

Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

Chat with this insight

Recent Analyst Ratings for $XRAY

$XRAY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 3 filed by new insider Garth Matthew E

Director Vergis Janet S. was granted 13,880 shares, increasing direct ownership by 46% to 43,981 units (SEC Form 4)

Director Varon Leslie F was granted 13,880 shares, increasing direct ownership by 41% to 47,687 units (SEC Form 4)

$XRAY Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

$XRAY Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$XRAY SEC Filings

Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)

Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)

Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form 10-Q filed by DENTSPLY SIRONA Inc.

$XRAY Financials

Live finance-specific insights

Dentsply Sirona Declares Quarterly Cash Dividend

Dentsply Sirona Reports First Quarter 2025 Results

Dentsply Sirona to Host First Quarter Conference Call on May 8th

$XRAY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Dentsply Sirona downgraded by Morgan Stanley with a new price target

Dentsply Sirona downgraded by Needham

Wells Fargo initiated coverage on Dentsply Sirona with a new price target

$XRAY Press Releases

Fastest customizable press release news feed in the world

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Declares Quarterly Cash Dividend

Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference

$XRAY Leadership Updates

Live Leadership Updates

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

Recent Analyst Ratings for
$XRAY

$XRAY
Insider Trading

$XRAY
Large Ownership Changes

$XRAY
Insider Purchases

$XRAY
SEC Filings

$XRAY
Financials

$XRAY
Analyst Ratings

$XRAY
Press Releases

$XRAY
Leadership Updates